The American people have spoken, and they're rejecting the Biden regime's reckless endangerment of women's health in the name of abortion ideology.
A stunning new poll conducted for the 85 Fund and reported by The Daily Wire shows that more than two-thirds of Americans oppose the Biden-era FDA rules that eliminated the requirement for women to see a doctor in-person before receiving dangerous abortion pills.
This overwhelming opposition cuts across party lines, proving that common sense still prevails among everyday Americans – even when Washington bureaucrats abandon basic medical safety protocols to appease the radical abortion lobby.
Biden's Dangerous Legacy
The poll results expose just how far the previous administration went to prioritize abortion access over women's safety. Under Biden's FDA, the agency stripped away crucial safeguards that required face-to-face medical consultations before dispensing powerful chemical abortion drugs.
Think about it: you need to see a doctor in-person for most prescription medications, but the Biden administration decided that potentially life-threatening abortion drugs could be handed out like candy through the mail.
"This poll confirms what we've known all along – the American people believe in common-sense medical safety, not radical ideology disguised as healthcare."
The timing of this poll couldn't be more significant. As President Trump's second administration works to restore sanity to federal agencies, these results provide a clear mandate for reforming the FDA's abortion pill policies.
What This Means for Trump's Agenda
Patriots can expect the Trump-Vance administration to take swift action on this issue. With strong public support for tighter safeguards, restoring proper medical oversight for abortion drugs should be an easy win for conservatives.
The poll also demonstrates how dramatically the Biden administration overreached on social issues, implementing policies that even moderate Americans found extreme and dangerous.
As Trump continues dismantling Biden's failed legacy, will the new FDA leadership restore the medical safeguards that protect women's health? The American people have already given their answer.